Selective therapeutic control of C5a and
✍
Fabio Fischetti; Paolo Durigutto; Paolo Macor; Roberto Marzari; Renzo Carretta;
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 337 KB
👁 2 views
## Abstract ## Objective To determine the role of the terminal complement complex (TCC) in the development of experimental antigen‐induced arthritis (AIA) and the therapeutic effects of human anti‐C5 single‐chain Fv (scFv). ## Methods Two different anti‐C5 scFv, one that inhibits both release of